Harry Kerasidis
Prince Frederick, MDNPI 1982665378
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $35,601 of the $38,823 with a category attached, or 91.7%. MDD US Operations, LLC accounts for 91.7% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2019 at $36,932 and has fallen 99.6% since, to $134 in 2022.
Across 193 payments — averaging $201.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$36K
- AbbVie$559
- Novartis$469
- Teva Pharmaceuticals USA, Inc.$205
- Lundbeck LLC$192
- Brainscope Company, Inc.$173
- plus $2K from 31 others
What the payments were for
- Speaking & faculty fees$370%
- Food & beverage$3,1858%
- Gifts$35,60192%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYOBLOC$35,601
- Modified BrainScope One$173
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.